PREVIEW: Abbott Laboratories (ABT) earnings due 26/Jan at 12:30GMT/07:30EST

Abbott Laboratories (ABT) Q4 2021 (USD): EPS (exp. 1.21/0.89 GAAP), Revenue (exp. 10.71bln)

REVENUE SEGMENTS:

• Diagnostics: (exp. 3.46bln)


• Established Pharmaceuticals: (exp. 1.25bln)


• Medical Devices: (exp. 3.77bln)


• Nutrition: (exp. 2.08bln)

DIVIDEND:

• Qtrly Dividend: (exp. 0.43)


• FY Dividend: (exp. 1.71)

EPS GUIDANCE:

• Q1 2021 EPS View: (exp. 1.13/0.77 GAAP)


• FY 2021 EPS View: (exp. 5.09/3.66 GAAP)

REVENUE GUIDANCE:

• Q1 2021 Revenue View: (exp. 9.82bln)


• FY 2021 Revenue View: (exp. 42.29bln)


• FY 2022 Revenue View: (exp. 40.41bln)

INDEX WEIGHT:

• 0.6% SPX weight


• Sector/Industry: Health Care/Health Care Equipment & Supplies

BROKER RATING:

• Avg Rating: 'Buy'


• Avg Price Target: USD 145.18


• Price Target Changes (last 30 days): 5 upward vs 0 downward

25 Jan 2022 - 17:00- Equities- Source: Newsquawk